A Pilot Study of Immunotherapy Combined with Stereotactic Ablative Radiotherapy for Patients with Advanced or Metastatic Sarcoma
Details
The purpose of this research study is to test if a combination of two treatments, immunotherapy and stereotactic ablative radiotherapy (SBRT), can delay tumor growth in patients with cancers that develop in their soft tissues (sarcomas).
Eligibility
You can join if...
Please note this may not be a complete list of eligibility criteria. We have included a few examples of study criteria to help you better understand how your eligibility in the study will be determined; your study team will go through the study eligibility criteria with you to verify if you qualify for participation in this study.
Inclusion Requirements
You can participate in this study if you satisfy the following criteria:
are at least 18 years of age or older
have been diagnosed with soft tissue sarcoma
are not a candidate for surgery based on your doctor’s assessment
Exclusion Requirements
You cannot participate in this study if you satisfy the following criteria: